돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 277738생성일: 2026년 10월 26일

L-Phenylalanine → (+)-Phenylahistin

https://huagongshe.com/reaction/277738

반응식

참여 물질

역할이름HCID투입량
반응물L-PhenylalanineHCID 6140—
반응물PhenylahistinHCID 9798496—
용매Ethanol hexaneHCID 21879635—
생성물(+)-PhenylahistinHCID 44328528—

반응 단계

It was also determined that phenylahistin has a chiral center at the C-10 position. Chiral HPLC analysis of the phenylalanine was conducted according to methods described in Larsen, T. O et al., Phytochemistry (1992) 31, 1613, under the following conditions: HPLC conditions: column; Crownpak CR(+)φ4.0×150 mm (Daicel Chemical Industries, Ltd.), mobile phase; H2O (pH 2, adjusted with perchloric acid), flow rate; 0.8 ml/min, detector; UV λ 200 nm. Phenylalanine was obtained from the acidic hydrolysate of the amorphous white powder of phenylahistin, see Yamazaki, M. et al., Tetrahedron Lett. (1975) 27. The phenylalanine obtained from the hydrolysate of phenylahistin was identified using an amino acid analyzer and by measurement of EI-MS [(m+H)+:166.2]); chrial HPLC indicated that the phenylahistin was a mixture of enantiomers in the ratio of approximately R:S=3.1. In order to examine the biological activity of each enantiomer, chiral resolution was carried out by chiral HPLC under the following conditions: column; Chiracel OD φ44.6×250 mm (Daicel Chemical Industries, Ltd), mobile phase; n-hexane/ethanol=75/25, flow rate; 1.0 ml/min, temperature; 25° C. Absolute configuration was determined by analysis of phenylalanine obtained from (+)-phenylahistin using chiral HPLC.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06358957B1
출처 데이터셋uspto-grants-2002_03
ORD IDord-f8b81421dcb948848ae6933c7f0f6579
출처 메모uspto-grants-2002_03